🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The first part of this study is to find the recommended dosages of a combin...
Status
Terminated
Location
Royal United Hospital Bath NHS Trust
Start Date
2014-09
Trial ID
NCT02055690
Treatments Being Tested
This is a pilot study of Pazopanib in patients with FGFR2 Amplification or ...
Status
Completed
Location
Samsung Medical Center
Start Date
2015-10-08
Trial ID
NCT02450136
Treatments Being Tested
This is an open-label, international, multi-center study designed to provid...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09
Trial ID
NCT00387764
Treatments Being Tested
This is a study of TRC105 in combination with standard dose pazopanib compa...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2017-02-13
Trial ID
NCT02979899
The purpose of this study is to determine the highest dose of Vinorelbine a...
Status
Terminated
Location
Northwestern University, Northwestern Medical Faculty Foundation
Start Date
2010-02
Trial ID
NCT01060514
Treatments Being Tested
The aim of this study is to evaluate the efficacy and safety of pazopanib c...
Status
Completed
Location
Annemasse - CH
Start Date
2008-11
Trial ID
NCT00775307
The purpose of this study is to determine how dosing with ketoconazole (Niz...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09
Trial ID
NCT01205230
Treatments Being Tested
The MOST Plus study is a two-period phase II clinical trial, conducted in p...
Status
Recruiting
Location
Institut Bergonié
Start Date
2014-03
Trial ID
NCT02029001
Pazopanib is an orally administered multi-kinase inhibitor targeting VEGFR ...
Status
Completed
Location
University of Michigan Comprehensive Cancer Center
Start Date
2016-06
Trial ID
NCT02729194
Treatments Being Tested
Information on the prevalence of advanced/metastatic renal cell carcinoma a...
Status
Completed
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01381601